Showing results (51-60 of 328) with videos related to

Sort By:
Pageof 33
Diabetes, Obesity & Metabolism|April 25, 2018
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trialsMark Warren, Louis Chaykin, David Trachtenbarg, et al.
Current Diabetes Reports|February 16, 2022
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO StudySarra Smati, Blandine Tramunt, Matthieu Wargny, et al.
Annales D'Endocrinologie|August 27, 2018
Expert opinion on the metabolic complications of mTOR inhibitorsBenjamin Bouillet, Perrine Buffier, Sarra Smati, et al.
Hepatology International|June 8, 2024
Review of current and new drugs for the treatment of metabolic-associated fatty liver diseaseRobert Gish, Jian-Gao Fan, Zahra Dossaji, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2023
Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk ProfilesJennifer Linge, Bertrand Cariou, Ian J Neeland, et al.
The Journal of Biological Chemistry|December 1, 2001
Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14Veronique Béréziat, Anne Kasus-Jacobi, Dominique Perdereau, et al.
Clinics and Research in Hepatology and Gastroenterology|August 19, 2019
Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patientsThomas Broussier, Adrien Lannes, Floraine Zuberbuhler, et al.
Atherosclerosis|September 6, 2011
Lack of association between plasma PCSK9 and LDL-apoB100 catabolism in patients with uncontrolled type 2 diabetesBruno Vergès, Laurence Duvillard, Marie Claude Brindisi, et al.
Stem Cell Research|March 5, 2022
Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1)Lise Bray, Amandine Caillaud, Aurore Girardeau, et al.
Pageof 33